We are creating some awesome events for you. Kindly bear with us.

Taiwan Partners with Baltic States in Quantum, Biotech

The Ministry of Science and Technology (MOST) stated that Taiwan will engage in cooperation and exchanges with the Baltic states in the areas of quantum technology and biotechnology. The two countries are expected to lead to future bilateral academic and research exchanges. Both countries will discuss technology development, biomedicine, semiconductors and technology parks.

The natios have concluded that the plans for future cooperation between Taiwan and the Baltic states – Lithuania, Latvia and Estonia – will focus on academic and research exchanges in the quantum technology and biotech areas.

This direction was chosen after considering the Baltic states’ position as members of the European Union, with varying levels of technological development and expertise, and Taiwan’s current policy on science and technology research. The ministry added the delegation, which includes the parliamentary representatives Matas Maldeikis of Lithuania, Janis Vucans of Latvia and Juri Jaanson of Estonia showed positive interest in supporting bilateral cooperation and exchanges in the field of technology.

Taiwan believes that quantum technology is coming and the country is investing to become a leader. Taiwan will invest NT$ 8 billion – about US$ 282 million – in the development of quantum technology in the coming five years with a view to becoming a tech hub that boasts more than semiconductor manufacturing prowess.

The initiative is much broader than just building a quantum computer, according to the story. The country will invest in quantum devices, quantum computers, quantum algorithms and quantum communication technologies. The new technologies will be employed to develop applications for areas spanning cybersecurity, finance, national defence and more. Taiwan must invest in quantum research before it can secure a place in the competitive world of advanced technologies.

Meanwhile, Taiwan’s biomedical industry has grown from strength to strength in recent years as a result of farsighted government policymaking, spotlighting her administration’s commitment to developing high-growth sectors of the economy.

Biomedical technology has been a top priority in Taiwan’s national development strategy. Over the past few years, the country has conducted over 300 clinical trials, 80% of which involved multinational firms, while local biomedical industry revenues grew 8.7% in 2019, with total investment exceeding NT$55.1 billion (US$1.84 billion).

Taiwan’s biomedical industry includes three major sectors: applied biotechnology, pharmaceuticals, and medical devices. Research institutes have played an important role in the development of Taiwan’s economy, and today no less than nine institutes are involved in the development of Biomedical Innovations in the country’s biomedical industry.

As reported by OpenGov Asia, MOST announced that 20 tech startup companies would showcase Taiwan’s Biotech capabilities to the world connect with the global ecosystem, resources and industries in the forum organised by Taiwan Tech Arena (TTA). There are 20 TTA startup teams are selected by industrial experts and focused on global bio-industrial market potential startups.

Taiwan has demonstrated how to democratically tackle the COVID-19 threatening and how to be a truly global partner by utilising technologies. Taiwan’s efforts and commitments have drawn international attention and the relationship between Taiwan and the U.S. has become stronger than ever before in the past year. The U.S. is leading the trends of advanced science and technology development and has a vivid startup ecosystem, while Taiwan has renowned semiconductor and ICT industries and long supported technology startups.

By working together, Taiwan can speed up the transition from scientific findings into practical technology applications and create a win-win situation and achieve future possible collaborations in the US. The companies presented disruptive biotech innovations such as vocal implant systems, AI Video-based telemedicine solutions and detection of respiratory function with ultrasound technology.

Send this to a friend